Do drug developers tip well? Is biotech safe for 6-year-olds? And what’s a Cable Car Cosmo?
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Like seemingly everyone even tangentially involved in biotech, we spent the week in San Francisco at the J.P. Morgan Healthcare Conference, the industry’s largest annual gathering. It’s where thousands of bankers, analysts, entrepreneurs, and investors gather each January to strike deals, talk stocks, and set the agenda for the year ahead.
This podcast is not about those people. CEOs and fund managers get enough attention, so we decided to present the story of J.P. Morgan through the eyes — and with the voices — of the Lyft drivers, bartenders, and hoteliers without whom biotech’s answer to Woodstock simply wouldn’t happen.
For more on what we cover, here’s the news on Bristol-Myers and Celgene; here’s a look at what we learned from the deal; and here’s how the CEOs involved explained their reasoning.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].